|
Pinaverium Impurity A
|
匹维铵杂质A
|
|
|
Etoricoxib
|
依托考昔
|
202409-33-4
|
|
Roxithromycin EP Impurity B
|
罗红霉素EP杂质B
|
214902-82-6
|
|
Voriconazole EP Impurity B
|
伏立康唑EP杂质B
|
182369-73-9
|
|
Tofacitinib Impurity N
|
托法替尼杂质 N
|
1260614-73-0
|
|
Tofacitinib Impurity J
|
托法替尼杂质 J
|
|
|
Roxithromycin Impurity H
|
罗红霉素杂质H
|
|
|
Irbesartan Impurity 13
|
厄贝沙坦杂质13
|
|
|
Tofacitinib Impurity U
|
托法替尼杂质 U
|
1616760-97-4
|
|
Indacaterol Impurity 2
|
茚达特罗杂质2
|
1026461-20-0
|
|
5-Hydroxy Valproic Acid Sodium Salt
|
5-羟基丙戊酸钠盐
|
78644-53-8
|
|
Irbesartan Related Compound A
|
厄贝沙坦相关化合物A
|
748812-53-5
|
|
Donepezil EP Impurity F;Donepezil USP Related Compound A
|
多奈哌齐EP杂质 F；多奈哌齐USP相关化合物A
|
145546-80-1
|
|
Voriconazole
|
伏立康唑
|
137234-62-9
|
|
Irbesartan Impurity 12
|
厄贝沙坦杂质12
|
160514-13-6
|
|
Tofacitinib Impurity F
|
托法替尼杂质 F
|
384338-23-2
|
|
Etoricoxib Impurity 7
|
依托考昔杂质7
|
646459-39-4
|
|
Donepezil Alkene Pyridine N-Oxide
|
多奈哌齐烯烃吡啶氮氧化物
|
2452407-68-8
|
|
Furosemide EP Impurity D
|
呋塞米EP杂质D
|
5046-19-5
|
|
Pinaverium Bromide Impurity 3
|
匹维溴铵杂质3
|
1126385-20-3
|
|
Valeric Acid;Valproic Acid EP Impurity A
|
戊酸；丙戊酸EP杂质A
|
109-52-4
|
|
Furosemide
|
呋塞米
|
54-31-9
|
|
Etoricoxib Impurity 37
|
依托考昔杂质37
|
58058-86-9
|
|
Tofacitinib Impurity 10
|
托法替尼杂质 10
|
477600-74-1
|
|
Voriconazole USP Related Compound A
|
伏立康唑相关化合物A
|
137330-52-0
|
|
Indacaterol Impurity 6 HCl
|
茚达特罗杂质6盐酸盐
|
312753-53-0
|
|
Valproic Acid Impurity 10
|
丙戊酸杂质10
|
109578-13-4
|
|
Tofacitinib Impurity R
|
托法替尼杂质 R
|
479633-63-1
|
|
Tofacitinib Impurity 24
|
托法替尼杂质 24
|
1092578-48-7
|
|
Voriconazole Related Compound D
|
伏立康唑相关化合物D
|
|
|
Tofacitinib Impurity T
|
托法替尼杂质 T
|
1092578-43-2
|
|
Roxithromycin Impurity K
|
罗红霉素杂质K
|
|
|
Valproic Acid EP Impurity B
|
丙戊酸EP杂质B
|
20225-24-5
|
|
Lenvatinib Impurity 13
|
仑伐替尼杂质13
|
|
|
Valproic Acid EP Impurity J
|
丙戊酸EP杂质J
|
5340-48-7
|
|
Tofacitinib Impurity C Citrate
|
托法替尼杂质 C 柠檬酸盐
|
1092578-47-6
|
|
Pinaverium Bromide Impurity 2
|
匹维溴铵杂质2
|
54370-00-2
|
|
Roxithromycin Impurity G
|
罗红霉素杂质G
|
425365-64-6
|
|
Indacaterol Impurity 7
|
茚达特罗杂质7
|
435273-75-9
|
|
Irbesartan Impurity 6
|
厄贝沙坦杂质6
|
138401-24-8
|
|
Tofacitinib Impurity L
|
托法替尼杂质 L
|
1675248-19-7
|
|
Tofacitinib Impurity I
|
托法替尼杂质 I
|
|
|
Roxithromycin EP Impurity D
|
罗红霉素EP杂质D
|
134931-00-3
|
|
Valproic Acid EP Impurity D
|
丙戊酸EP杂质D
|
52061-75-3
|
|
Tofacitinib Impurity W
|
托法替尼杂质 W
|
|
|
Pinaverium Bromide
|
匹维溴铵
|
53251-94-8
|
|
Tofacitinib Impurity X
|
托法替尼杂质 X
|
|
|
Voriconazole Impurity E
|
伏立康唑杂质E
|
5872-08-2
|
|
Irbesartan
|
厄贝沙坦
|
138402-11-6
|
|
Furosemide Impurity 2
|
呋塞米杂质 2
|
41332-59-6
|
|
Irbesartan Impurity 5
|
厄贝沙坦杂质5
|
141745-36-0
|
|
Roxithromycin EP Impurity F
|
罗红霉素EP杂质F
|
118267-18-8
|
|
Roxithromycin EP Impurity C
|
罗红霉素EP杂质C
|
111321-02-9
|
|
Irbesartan Impurity 7
|
厄贝沙坦杂质7
|
141745-71-3
|
|
Tofacitinib Impurity 39
|
托法替尼杂质 39
|
923036-30-0
|
|
Irbesartan N-Trityl Impurity
|
厄贝沙坦N-三苯甲基杂质
|
|
|
Valproic Acid Impurity F
|
丙戊酸杂质F
|
|
|
Irbesartan Impurity 4
|
厄贝沙坦杂质4
|
945540-26-1
|
|
Furosemide EP Impurity C
|
呋塞米EP杂质C
|
3086-91-7
|
|
Furosemide EP Impurity B
|
呋塞米EP杂质B
|
2736-23-4
|
|
Etoricoxib Impurity 36
|
依托考昔杂质36
|
33963-58-5
|
|
Etoricoxib N-Oxide
|
依托考昔氮氧化物
|
325855-74-1
|
|
Tofacitinib Impurity 9
|
托法替尼杂质 9
|
477600-73-0
|
|
Tofacitinib Impurity 42
|
托法替尼杂质 42
|
1092578-46-5
|
|
Irbesartan Impurity 9
|
厄贝沙坦杂质9
|
1079997-01-5
|
|
Donepezil Impurity 2
|
多奈哌齐杂质2
|
36517-91-6
|
|
Roxithromycin EP Impurity J HCl
|
罗红霉素EP杂质J盐酸盐
|
134834-12-1
|
|
Indacaterol Impurity 1
|
茚达特罗杂质1
|
1403389-05-8
|
|
Tofacitinib Impurity V
|
托法替尼杂质 V
|
|
|
Roxithromycin N-Oxide
|
罗红霉素N-氧化物
|
1460313-73-8
|
|
Valproic Acid EP Impurity C
|
丙戊酸EP杂质C
|
62391-99-5
|
|
Donepezil N-Oxide
|
多奈哌齐N-氧化物
|
120013-84-5
|
|
Valproic Acid Impurity 9
|
丙戊酸杂质9
|
|
|
Valproic Acid EP Impurity I
|
丙戊酸EP杂质L
|
13310-75-3
|
|
Donepezil EP Impurity D
|
多奈哌齐EP杂质D
|
4803-57-0
|
|
Valproic Acid
|
丙戊酸
|
99-66-1
|
|
Indacaterol Impurity 5
|
茚达特罗杂质5
|
173140-90-4
|
|
Indacaterol Maleate
|
马来酸茚达特罗
|
753498-25-8
|
|
Etoricoxib Impurity 35
|
依托考昔杂质35
|
300355-18-4
|
|
Tofacitinib Impurity P
|
托法替尼杂质 P
|
1252883-90-1
|
|
(S)-Indacaterol
|
(S)-茚达特罗
|
1235445-80-3
|
|
Roxithromycin Impurity E
|
罗红霉素杂质E
|
|
|
Valproic Acid EP Impurity K
|
丙戊酸EP杂质K
|
5343-52-2
|
|
Voriconazole EP Impurity D;Voriconazole Enantiomer
|
伏立康唑 EP 杂质 D；伏立康唑对映异构体
|
137234-63-0
|
|
Furosemide EP Impurity A
|
呋塞米EP杂质A
|
4818-59-1
|
|
Etoricoxib Impurity 5 Lithium Salt
|
依托考昔杂质 5 锂盐
|
1421227-96-4
|
|
Pinaverium Bromide Impurity 1
|
匹维溴铵杂质1
|
|
|
Irbesartan Impurity 10;Irbesartan Dimer
|
厄贝沙坦杂质10;厄贝沙坦二聚体
|
1346598-52-4
|
|
Voriconazole EP Impurity C
|
伏立康唑EP杂质C
|
137234-88-9
|
|
Valproic Acid EP Impurity L
|
丙戊酸EP杂质L
|
97-61-0
|
|
Tofacitinib Impurity Q
|
托法替尼杂质 Q
|
3680-69-1
|
|
Etoricoxib Impurity D
|
依托考昔杂质D
|
221615-75-4
|
|
Valproic Acid Related Compound A
|
丙戊酸相关化合物A
|
99-67-2
|
|
Tofacitinib Citrate
|
托法替尼枸橼酸盐
|
540737-29-9
|
|
Furosemide EP Impurity E
|
呋塞米EP杂质E
|
50-84-0
|
|
Valproic Acid related compound B
|
丙戊酸相关化合物B
|
|
|
Furosemide EP Impurity F
|
呋塞米EP杂质F
|
4793-38-8
|
|
Etoricoxib Impurity 34
|
依托考昔杂质34
|
|
|
Valproic Acid Related Compound A Sodium Salt
|
丙戊酸相关化合物A钠盐
|
76944-37-1
|
|
Etoricoxib Impurity 29
|
依托考昔杂质29
|
5470-70-2
|
|
Valproic Acid EP Impurity G
|
丙戊酸EP杂质G
|
52061-73-1
|